Literature DB >> 18477467

Serotonin systems upregulate the expression of hypothalamic NUCB2 via 5-HT2C receptors and induce anorexia via a leptin-independent pathway in mice.

Katsunori Nonogaki1, Yukie Ohba, Makiko Sumii, Yoshitomo Oka.   

Abstract

NEFA/nucleobindin2 (NUCB2), a novel satiety molecule, is associated with leptin-independent melanocortin signaling in the central nervous system. Here, we show that systemic administration of m-chlorophenylpiperazine (mCPP), a serotonin 5-HT1B/2C receptor agonist, significantly increased the expression of hypothalamic NUCB2 in wild-type mice. The increases in hypothalamic NUCB2 expression induced by mCPP were attenuated in 5-HT2C receptor mutant mice. Systemic administration of mCPP suppressed food intake in db/db mice with leptin receptor mutation as well as lean control mice. On the other hand, the expression of hypothalamic NUCB2 and proopiomelanocortin (POMC) was significantly decreased in hyperphagic and non-obese 5-HT2C receptor mutants compared with age-matched wild-type mice. Interestingly, despite increased expression of hypothalamic POMC, hypothalamic NUCB2 expression was decreased in 5-HT2C receptor mutant mice with heterozygous mutation of beta-endorphin gene. These findings suggest that 5-HT systems upregulate the expression of hypothalamic NUCB2 via 5-HT2C receptors, and induce anorexia via a leptin-independent pathway in mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18477467     DOI: 10.1016/j.bbrc.2008.05.010

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  Sleep and rhythm consequences of a genetically induced loss of serotonin.

Authors:  Smaranda Leu-Semenescu; Isabelle Arnulf; Caroline Decaix; Fathi Moussa; Fabienne Clot; Camille Boniol; Yvan Touitou; Richard Levy; Marie Vidailhet; Emmanuel Roze
Journal:  Sleep       Date:  2010-03       Impact factor: 5.849

Review 2.  A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment.

Authors:  Jose M Palacios; Angel Pazos; Daniel Hoyer
Journal:  Psychopharmacology (Berl)       Date:  2017-03-07       Impact factor: 4.530

3.  Expression of nesfatin-1/NUCB2 in rodent digestive system.

Authors:  Ai-Qing Zhang; Xue-Liang Li; Chun-Ying Jiang; Lin Lin; Rui-Hua Shi; Jian-De Chen; Yutaka Oomura
Journal:  World J Gastroenterol       Date:  2010-04-14       Impact factor: 5.742

Review 4.  Minireview: nesfatin-1--an emerging new player in the brain-gut, endocrine, and metabolic axis.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Endocrinology       Date:  2011-08-23       Impact factor: 4.736

Review 5.  Nesfatin-1: a novel inhibitory regulator of food intake and body weight.

Authors:  A Stengel; M Goebel; Y Taché
Journal:  Obes Rev       Date:  2011-04       Impact factor: 9.213

Review 6.  Nesfatin-1--role as possible new potent regulator of food intake.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Regul Pept       Date:  2010-05-16

7.  Role of NUCB2/Nesfatin-1 in the hypothalamic control of energy homeostasis.

Authors:  A Stengel; Y Taché
Journal:  Horm Metab Res       Date:  2013-09-18       Impact factor: 2.936

8.  Gastric peptides and their regulation of hunger and satiety.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Curr Gastroenterol Rep       Date:  2012-12

Review 9.  The role of nesfatin-1 in the regulation of food intake and body weight: recent developments and future endeavors.

Authors:  A Stengel; M Mori; Y Taché
Journal:  Obes Rev       Date:  2013-08-27       Impact factor: 9.213

10.  Novel SNPs of the bovine NUCB2 gene and their association with growth traits in three native Chinese cattle breeds.

Authors:  F Li; H Chen; C Z Lei; G Ren; J Wang; Z J Li; J Q Wang
Journal:  Mol Biol Rep       Date:  2010-01       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.